Offerings
Uses
The Race
About Us
Resources
Create a CKB Account
Create a mastermind account

Clinical Diagnostics

Accelerate NGS variant interpretation with rapid search and insight into the full text of the genomic literature

Clinical Uses

Precision Therapeutics

Partner with us to gain a comprehensive view of the genetics of your disease of interest, from discovery to commercialization

Pharma Uses

Software Solutions

Explore our platforms for germline and somatic variant interpretation


Access article information on more than 26 million variants, as well as curated germline variant content.

Meet Mastermind

Our Cancer Knowledgebase is used to interpret cancer variants, connecting them to therapies and clinical trials


Meet CKB

Services

Partner with our team of experts to create Tailored Solutions for your unique needs

Clinical Diagnostic Services
Precision Therapeutics Services

Data

Gain access to an expansive, constantly updated database of curated genomic information

Learn More
Offerings
Software
Clinical Diagnostics Services
Precision Therapeutics Services
Data
Somatic Knowledgebase
Uses
The Race
About Us
Resources
schedule a discovery call
Create a mastermind account
Create a CKB Account
< Resources

Case Study

Genomenon and BeginNGS: The Promising Future of Newborn Sequencing

‍

The new BeginNGS™ program, based at the Rady Children’s Institute for Genomic Medicine (RCIGM), is a novel health care delivery system designed to screen newborns for genetic diseases and connect their doctors with effective treatment options. It will improve infant patient outcomes by providing clinicians with powerful insight on how these diseases form, and how to treat them, creating life-saving opportunities for patients and their families at very early stages.

‍

‍

Mastermind: The premier resource of BeginNGS

As part of our mission to curate the entire human genome, Genomenon will combine AI-powered organization and expert manual review to fully curate all the genes in the BeginNGS screening panel – genes tied to over 400 diseases – and provide RCIGM with a comprehensive, actionable dataset on the variants that are found to cause disease. Read more here.

‍

‍

Download PDF
The World’s Most Comprehensive Source of Genomic Evidence

Mastermind accelerates variant interpretation with immediate insight into the full text of millions of scientific articles. Prioritize your search results by clinical relevance and find what you are looking for 5-10 times faster

Create your free account
The Most Comprehensive Source of Curated Genomic Evidence + Scientific Experts

We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.

Contact Us
Offerings
SoftwarePrecision Therapeutics ServicesClinical Diagnostic ServicesData Access
Uses
Clinical UsesPharmaceutical Uses
The Race
About Us
Resources
Careers
News, Press & Events
Investors
Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Citing MastermindTerms & ConditionsPrivacy PolicyCopyright © 2024 Genomenon, Inc. All rights reserved.